Abstracts

Health

Search abstracts:

No-fault and enterprise liability: the view from Utah

Article Abstract:

No-fault liability and enterprise liability may eliminate the flaws of the existing system of patient compensation. A Utah coalition led by the Utah Medical Association is planning to test its Experiment in Patient Injury Compensation (EPIC) at certain medical facilities. Compensation for patient injury will be awarded if it is determined that the injury was an avoidable consequence of the medical care the patient received. Patient claims will be evaluated by a claims adjuster at the medical facility, who will also decide the award amount based on policies. Hospitals and physicians will be responsible for payment, and they will continue to carry liability insurance. The reduced emphasis on proving negligence should relieve doctors from practicing defensive medicine, which should reduce health care costs.

Editorial, Laws, regulations and rules, Tort reform, Personal injuries, Malpractice, Utah

---

Legal aid for strict liability claims

Article Abstract:

Legal aid has been granted to four Britons who wish to sue pharmaceutical concern Roche Products over the anti-acne drug Roaccutane, which they allege has prompted suicidal feelings. It is possible that this development will spark off a large number of cases against Roche. Indeed, the World Health Organisation believes that Roaccutane has been involved in 720 reported psychiatric difficulties and 100 suicides or attempted suicides internationally. Claims for compensation by patients who took the drug after 1998 are unlikely to succeed, as by that time Roche had included warnings about possible psychiatric problems in its information sheet.

Cases, Pharmaceutical industry, Drug therapy, Failure to warn (Law), Acne, Roche Products Ltd.

---

Product development horizons: a view from industry

Article Abstract:

The formulation of a new hydrolysates by combining appropriate enzymes, heat treatment and downstream processing to produce more palatable is emphasized for wide use with confidence and safety. This enzymes is seen to offer faster processing and enhanced yields of soluble, hypoallergenic peptides. This hydrolysates can become useful ingredients in the preparation of hypoallergenic formulas. The necessity of expecting the wide use of this formula in future emphasized.

Analysis, Antigens, Protein hydrolysates

Similar abstracts:

• Abstracts: Dose-related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate
• Abstracts: Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition. Biopsy proven and biopsy negative temporal areteritis: differences in clinical spectrum at the onset of the disease
• Abstracts: The role and responsibilities of the service coordinator in early intervention. The battle over homework
• Abstracts: The class I and class II proteins of the human major histocompatibility complex. Proper use of beryllium-containing alloys
• Abstracts: Neurotoxicity related to the use of tropical tretinoin (Retin-A). Firearm Related Deaths: The Impact of Regulatory Reform

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.